BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 36307509)

  • 1. DeepLPI: a novel deep learning-based model for protein-ligand interaction prediction for drug repurposing.
    Wei B; Zhang Y; Gong X
    Sci Rep; 2022 Oct; 12(1):18200. PubMed ID: 36307509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DeepLPI: a multimodal deep learning method for predicting the interactions between lncRNAs and protein isoforms.
    Shaw D; Chen H; Xie M; Jiang T
    BMC Bioinformatics; 2021 Jan; 22(1):24. PubMed ID: 33461501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of protein N-terminal acetylation modification sites based on CNN-BiLSTM-attention model.
    Ke J; Zhao J; Li H; Yuan L; Dong G; Wang G
    Comput Biol Med; 2024 May; 174():108330. PubMed ID: 38588617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MaTPIP: A deep-learning architecture with eXplainable AI for sequence-driven, feature mixed protein-protein interaction prediction.
    Ghosh S; Mitra P
    Comput Methods Programs Biomed; 2024 Feb; 244():107955. PubMed ID: 38064959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting drug-target interaction network using deep learning model.
    You J; McLeod RD; Hu P
    Comput Biol Chem; 2019 Jun; 80():90-101. PubMed ID: 30939415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HN-PPISP: a hybrid network based on MLP-Mixer for protein-protein interaction site prediction.
    Kang Y; Xu Y; Wang X; Pu B; Yang X; Rao Y; Chen J
    Brief Bioinform; 2023 Jan; 24(1):. PubMed ID: 36403092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DeepDTA: deep drug-target binding affinity prediction.
    Öztürk H; Özgür A; Ozkirimli E
    Bioinformatics; 2018 Sep; 34(17):i821-i829. PubMed ID: 30423097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An improved deep learning method for predicting DNA-binding proteins based on contextual features in amino acid sequences.
    Hu S; Ma R; Wang H
    PLoS One; 2019; 14(11):e0225317. PubMed ID: 31725778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential SARS-CoV-2 nonstructural proteins inhibitors: drugs repurposing with drug-target networks and deep learning.
    Azmoodeh SK; Tsigelny IF; Kouznetsova VL
    Front Biosci (Landmark Ed); 2022 Apr; 27(4):113. PubMed ID: 35468672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DeepCDA: deep cross-domain compound-protein affinity prediction through LSTM and convolutional neural networks.
    Abbasi K; Razzaghi P; Poso A; Amanlou M; Ghasemi JB; Masoudi-Nejad A
    Bioinformatics; 2020 Nov; 36(17):4633-4642. PubMed ID: 32462178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A deep learning-based method for drug-target interaction prediction based on long short-term memory neural network.
    Wang YB; You ZH; Yang S; Yi HC; Chen ZH; Zheng K
    BMC Med Inform Decis Mak; 2020 Mar; 20(Suppl 2):49. PubMed ID: 32183788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A deep learning method for repurposing antiviral drugs against new viruses via multi-view nonnegative matrix factorization and its application to SARS-CoV-2.
    Su X; Hu L; You Z; Hu P; Wang L; Zhao B
    Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34965582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A New Hybrid Neural Network Deep Learning Method for Protein-Ligand Binding Affinity Prediction and De Novo Drug Design.
    Limbu S; Dakshanamurthy S
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Employing Molecular Conformations for Ligand-Based Virtual Screening with Equivariant Graph Neural Network and Deep Multiple Instance Learning.
    Gu Y; Li J; Kang H; Zhang B; Zheng S
    Molecules; 2023 Aug; 28(16):. PubMed ID: 37630234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting target-ligand interactions with graph convolutional networks for interpretable pharmaceutical discovery.
    Ruiz Puentes P; Rueda-Gensini L; Valderrama N; Hernández I; González C; Daza L; Muñoz-Camargo C; Cruz JC; Arbeláez P
    Sci Rep; 2022 May; 12(1):8434. PubMed ID: 35589824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-Target Interaction Prediction: End-to-End Deep Learning Approach.
    Monteiro NRC; Ribeiro B; Arrais JP
    IEEE/ACM Trans Comput Biol Bioinform; 2021; 18(6):2364-2374. PubMed ID: 32142454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug repositioning of COVID-19 based on mixed graph network and ion channel.
    Wang X; Li Q; Liu Y; Du Z; Jin R
    Math Biosci Eng; 2022 Jan; 19(4):3269-3284. PubMed ID: 35341251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ResBiGAAT: Residual Bi-GRU with attention for protein-ligand binding affinity prediction.
    Aly Abdelkader G; Ngnamsie Njimbouom S; Oh TJ; Kim JD
    Comput Biol Chem; 2023 Dec; 107():107969. PubMed ID: 37866117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attention-assisted hybrid 1D CNN-BiLSTM model for predicting electric field induced by transcranial magnetic stimulation coil.
    Sathi KA; Hosain MK; Hossain MA; Kouzani AZ
    Sci Rep; 2023 Feb; 13(1):2494. PubMed ID: 36781975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deep Neural Network Based Predictions of Protein Interactions Using Primary Sequences.
    Li H; Gong XJ; Yu H; Zhou C
    Molecules; 2018 Aug; 23(8):. PubMed ID: 30071670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.